NCT07416799Recruiting
Feasibility and Adherence to a Technology-assisted Home-based Strength Training Program in Adults With Type 2 Diabetes Mellitus and Mild Cognitive Impairment
Source: ClinicalTrials.gov · Last updated 11 May 2026
Brief summary (registry, in English)
This is a single-arm feasibility study employing a pre-post design with a 12-week intervention period. The study utilizes a telehealth-assisted home-based resistance exercise program, with a structured progression from supervised to unsupervised sessions over 12 weeks.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 2 Feb 2026
- Start date
- Apr 2026
- Primary completion date
- Mar 2027
- Lead sponsor
- The University of Texas Medical Branch, Galveston
- Diseases
- Type 2 diabetes
- NCT number
- NCT07416799
What you commit to
- Study type: Interventional
- Planned participants: 20
- From Apr 2026 to the primary completion date, Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concomitant medications with significant cholinergic or anticholinergic effects or adverse effects on cognition, including antipsychotics, tricyclic antidepressants, anticonvulsants, sedative/hypnotics, anxiolytics, glucocorticoids (chronic or frequent intermittent),
Other illness
- Diagnosis of movement disorders such as multiple sclerosis, parkinson's disease
- Diagnosis of Alzheimer's disease,
- Current diagnosis of severe depression, major psychiatric conditions such as bipolar disorder, psychosis, schizophrenia, or alcoholism that could affect the ability to understand and/or cooperate fully with the protocol.
- Significant cerebral vascular disease
- Visual/hearing impairment that would significantly impact the ability to participate in psychometric testing.
- Significant medical illness or organ failure, including hepatic or renal failure, unstable cardiac disease,
- Uncontrolled hypertension: over 160 mmHg systolic or 100 mmHg diastolic (stable treatment is allowable).
- Exercise Contraindications: Any condition that would make moderate-intensity exercise unsafe such as a history of severe aortic stenosis, poorly controlled hypertension, angina, or syncope.
Lab values
- Stage 5 renal impairment (GFR less than 15 or dialysis).
Other
- Untreated B12 deficiency or hypothyroidism (stable treatment for at least 3 months is allowable).
- Participation in another clinical trial.
- Prisoners.
- Lack of Support: No available caregiver or support person for technology assistance
Who the study is looking for
- Age: 55-80 years
- Diabetes: Diagnosed T2DM with ≥5 years duration
- Cognitive Status: Mild cognitive impairment as defined by Petersen criteria and confirmed by Montreal Cognitive Assessment (MoCA) scores of 18-25
- Medication Stability: Stable medication regimen for at least 3 months
- Physical Capability: Physically capable of participating in moderate-intensity exercise (physician clearance required)
- Support System: Having a caregiver or support person willing to assist with technology use if needed
Age in the registry: 55 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Texas Medical Branch - Galveston Coordinator of this site? Confirm its status | Galveston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.